SG

Saurabh Gupta

Active Director Director DIN 10569931
DIN 10569931 First appointment Mar 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Saurabh Gupta

Data last updated:

Saurabh Gupta is a Director at Savapill Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10569931
Primary Designation Director
Industry Paper
First Appointment 29 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20242024Active

Board colleagues of Saurabh Gupta

NameDINCompanyDesignation
Shivali Agrawal10683861Savapill Pharmaceuticals Private LimitedAdditional Director
Tannu Gupta05359797Savapill Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Savapill Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saurabh Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saurabh Gupta

Saurabh Gupta currently holds 1 directorship: Savapill Pharmaceuticals Private Limited (Director, since 29 Mar 2024).

Saurabh Gupta was first appointed on 29 Mar 2024 as Director at Savapill Pharmaceuticals Private Limited.

The current boards of Saurabh Gupta's companies include Shivali Agrawal (Savapill Pharmaceuticals Private Limited), Tannu Gupta (Savapill Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available